Research ArticleCancer

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

See allHide authors and affiliations

Science Translational Medicine  11 Sep 2019:
Vol. 11, Issue 509, eaaw8412
DOI: 10.1126/scitranslmed.aaw8412

Article Information

vol. 11 no. 509

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication January 29, 2019
  • Resubmitted June 19, 2019
  • Accepted for publication August 1, 2019
  • .

Author Information

  1. Ann Lin1,2,*,
  2. Christopher J. Giuliano1,2,*,
  3. Ann Palladino1,
  4. Kristen M. John1,3,
  5. Connor Abramowicz1,4,
  6. Monet Lou Yuan1,5,
  7. Erin L. Sausville1,
  8. Devon A. Lukow1,2,
  9. Luwei Liu1,2,
  10. Alexander R. Chait1,
  11. Zachary C. Galluzzo1,
  12. Clara Tucker1,2 and
  13. Jason M. Sheltzer1,
  1. 1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
  2. 2Stony Brook University, Stony Brook, NY 11794, USA.
  3. 3Hofstra University, Hempstead, NY 11549, USA.
  4. 4New York Institute of Technology, Glen Head, NY 11545, USA.
  5. 5Syosset High School, Syosset, NY 11791, USA.
  1. Corresponding author. Email: sheltzer{at}cshl.edu
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: September 2019 to June 2021

AbstractFullPdf
Sep 201927886238518955
Oct 2019950926441485
Nov 201931951149623
Dec 201921961858640
Jan 202020051740687
Feb 20202302593285
Mar 20201642361209
Apr 20201402272188
May 20201201202141
Jun 2020947241151
Jul 2020812207130
Aug 2020791232124
Sep 20204191190402
Oct 2020361627549
Nov 2020241108482
Dec 2020361063324
Jan 2021331233578
Feb 202123819343
Mar 2021151075383
Apr 2021271164253
May 202122975290
Jun 2021191672607

Stay Connected to Science Translational Medicine

Navigate This Article